High levels of CBA activate sphingosine 1-phosphate receptor 2 (S1PR2) to activate pro-inflammatory and fibrosis pathways, which promotes the progression of non-alcoholic steatohepatitis (NASH). Here, S1PR2 is linked to metabolic dysfunction-associated steatohepatitis.